Trials for Trials Against Analyzing Efficacy of Glucosamine and Chondroitine for Osteoarthritis
New approach to find effective remedies against osteoarthritis (OA) is actual because total treatment failure. Simultaneous existence of data explaining efficacy of glucosamine and chondroitine against osteoarthritis along with articles certifying failure of such effect raise permanent discussion. This controversy is extended with assessment of proposed infectious theory of osteoarthritis. There are several lines of suspicion for involvement of infectious factors in development of osteoarthritis and for antibacterial properties of glucosamine and chondroitine. From this view possible explanations of the trials’ discrepans in GS-CS efficacy-failure against osteoarthritis follow. Along with ethiology different clinical aspects and mechanisms should not be missed in patients with OA, which may be due to infectious factors. Large meta-analysis trials may miss important information considering large non-specific cogorts of patients. There are several teaching points for further investigation in this letter. Large meta-analysis studies cannot take into account all specific groups of patients and general data may miss an important information. In order to realize a nature of osteoarthritis specific homogenous groups for each parameter should be collected and examined. Occasional data may cary light for deep mechanisms of the disease and its therapy.
References
-
Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, et al. (2006) Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis. NEJM 354(8): 795-808.
-
Altman RD, Abadie E, Avouac B, Branco J, Bruyere O, et al. (2005) Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage: 13(1): 13-19.
-
Herrero-Beaumont G, Roman Ivorra JA, del Carmen- Trabado M, Blanco FJ, Benito P, et al. (2007) Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, doubleblind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 56(2): 555-567.
-
Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, et al. (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75(1): 37-44.
-
Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, et al. (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomized, placebo- controlled clinical trial. Lancet 357(9252): 251-256.
-
Reginster JY, Kahan A, Vignon E (2006) A two-year prospective, randomized, double-blind, controlled study assessing the effect of chondroitine 4&6 sulfate on the structural progression of knee osteoarthritis: STOPP (Study on Osteoarthritis Progression Prevention) ACR: L42.
-
Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, et al. (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (341): c4675.
-
Runhaar J, Rozendaal RM, van Middelkoop M, Bijlsma HJW, Doherty M, et al. (2017) Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data metaanalysis from the OA trial bank. Ann Rheum Dis 76(11): 1862-1869.
-
Leena S (2021) Osteoarthritis of the Knee. NEJM 384(1): 51-59.
-
Persiani S, Rotini R, Trisolino G, Rovati LC, Locatelli M, et al. (2007) Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis and Cartilage 15(7): 764-772.
-
Sarrazin S, Bonnaffe D, Lubineau A, Lortat-Jacob H (2005) Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon- gamma inhibits the cytokine activity. J Biol Chem 280(45): 37558-37564.
-
Chen JT, Liang JB, Chou CL, Chien MW, Shyu RC, et al. (2006) Glucosamine sulfate inhibits TNF-alpha and IFN- gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci 47(2): 664-672.
-
Chen JT, Chen CH, Horng CT, Chien MW, Lu DW, et al. (2006) Glucosamine sulfate inhibits proinflammatory cytokine- induced icam-1 production in human conjunctival cells in vitro. J Ocul Pharmacol Ther 22(6): 402-416.
-
Chen JT, Chen PL, Chang YH, Chien MW, Chen YH, et al. (2006) Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro. Exp Eye Res 83(5): 1052-1062.
-
Rozin AP, Goldstein M, Sprecher H (2008) Antibacterial activity of glucosamine sulfate and chondroitine sulfate? Clin. Exp. Rheum 26(3): 509-510.
-
Rozin AP (2009) Glucosamine sulfate – environmental antibacterial activity. Clin. Rheumatol 28: 1221-1223.
-
Rozin AP (2010) Antibiotic therapy for osteoarthritis? Medicina. Interna (Rom) (7): 61-66.
-
Rozin AP, Dolnikov K, Balbir-Gurman A (2022) New Quantitative Non-Radiologic Assessment of Osteoarthritis and Possible Infection Association. Int. J. Clin. Rheumatol 17(1): 09-15.
- Psychogenic Erectile Dysfunction in Late Adulthood: A Case Report on Clinical Intervention and Intimacy Restoration
- Clinical Trials on COVID-19 in 2025: A New Chapter in Global Health Research
- Innovations and Challenges in Contemporary Medical Clinical Trials: An Editorial Perspective
- Innovations and Challenges in Contemporary Medical Clinical Trials: A Critical Perspective
- Reimagining Clinical Trials: The Power of Continuous Feedback from Medical Reports
- Factors Influencing Brain Drain: Perspectives from a Medical School in Turkey